---
id: 038
title: Aminoglycoside Dosing - Once-Daily vs Synergy
category: antimicrobials
subcategory: aminoglycosides
tags: [aminoglycoside, once-daily, synergy, Hartford-nomogram, endocarditis]
difficulty: medium
---

## Question

Compare **once-daily** vs **synergy** dosing strategies for aminoglycosides. When is each approach used?

## Answer

### **Two Dosing Strategies:**

| Feature | Once-Daily (Extended-Interval) | Synergy Dosing |
|---------|-------------------------------|----------------|
| **Dose** | 5-7 mg/kg q24h | 1 mg/kg q8h or 1.5 mg/kg q12h |
| **Target Cmax/MIC** | >10 | Not applicable |
| **Indication** | Gram-negative infections | Gram-positive infections (with β-lactam) |
| **Examples** | Sepsis, pneumonia, UTI | Endocarditis, bacteremia |
| **Monitoring** | Random level 6-14h post-dose (Hartford) | Trough <1 mg/L |
| **Rationale** | Concentration-dependent killing + PAE | Synergy with cell wall agents |

### **Once-Daily Dosing (Hartford Nomogram):**

**Dosing:**
- Gentamicin or tobramycin: **7 mg/kg IV** (round to nearest 20-40mg)
- Amikacin: **15 mg/kg IV**

**Monitoring:**
1. Random level 6-14 hours after **start** of first infusion
2. Use nomogram to determine next dose interval (q24h, q36h, q48h)
3. Target: Level in "acceptable" zone on nomogram

**Advantages:**
- ↑ Cmax → better bacterial kill
- ↓ Toxicity (lower trough exposure)
- Easier to administer
- Cost-effective

### **Synergy Dosing:**

**When to Use:**
- **Enterococcal endocarditis** (ampicillin or vancomycin + gentamicin)
- **Staphylococcal endocarditis** (nafcillin + gentamicin - optional, controversial)
- **Streptococcal endocarditis** (penicillin + gentamicin for 2 weeks)

**Dosing:**
- Gentamicin: **1 mg/kg q8h** or **1.5 mg/kg q12h** (NOT once-daily)
- Target trough: <1 mg/L

**Key Point:** Once-daily dosing **NOT validated** for endocarditis synergy

## Key Points

### **When NOT to Use Once-Daily Dosing:**
- Endocarditis (use synergy dosing)
- Pregnancy
- Burns (>20% BSA)
- Ascites
- CrCl <30 mL/min (individualize)
- Cystic fibrosis (altered PK)

### **Monitoring:**
- **Once-daily:** Hartford nomogram (random level 6-14h)
- **Synergy:** Trough only (<1 mg/L)
- **Both:** SCr every 2-3 days, hearing assessment if >5 days

### **Hartford Nomogram Interpretation:**
- Level in "q24h zone" → Continue q24h
- Level in "q36h zone" → Switch to q36h
- Level in "q48h zone" → Switch to q48h
- Level too high → Hold dose, recheck level

## Sources

- [Stanford Aminoglycoside Dosing Guideline]
- [Pharmacy Times: Once-Daily Aminoglycoside Dosing Guide]
- [PMC: Aminoglycoside Dosing Regimen for Enterococcal Endocarditis]

## Media

N/A
